News | Cardio-oncology | January 28, 2019

ACC Hosts Third Annual Cardio-Oncology Course

Attendees access clinically relevant, best practice strategies for unique patient population

ACC Hosts Third Annual Cardio-Oncology Course

January 28, 2019 — The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology Patient course in Washington on Jan. 25-27, 2019. The event brought together top experts in both cardiology and oncology to review new and relevant science in this rapidly evolving field.

Research continues to show the link between cancer and heart disease, and in response, the field of cardio-oncology is rapidly growing. The ACC convenes this course so that both the novice and advanced clinician in the interprofessional field has access to clinically relevant, state-of-the-art, best practice strategies to ensure patients receive the most informed care possible. Ana Barac, M.D., FACC, and Bonnie Ky, M.D., MSCE, FACC, served as co-chairs of the conference, which featured educational content to provide clinicians and researchers with the tools needed to improve patient care in everyday practice.

“Over 14 million cancer patients and survivors are believed to have significant heart disease risk,” Barac said. “It is critical that cardiologists, oncologists and the entire multi-professional care team works together to ensure these patients not only win the battle with cancer, but don’t lose one with heart disease.”

ACC President C. Michael Valentine, M.D., FACC, opened the course with a TED Talk-style lecture, “Teamwork Makes the Dream Work: Partnerships in Care for the Cardio-Oncology Patient.” Other key sessions included:

  • Guideline-Driven Care Across the Lifespan: Where is the Evidence? Where are the Gaps?
  • Where is the Science Headed? Answers from the National Cancer Institute and Leading Experts
  • Live with the Experts: Team Challenges in Prediction, Prevention and Treatment

For the first time the course included poster presentations of new science. Some of the posters being presented included:

  • Tachycardia as a Predictor of All-Cause Mortality in Cancer Patients
  • Hybrid Breast/Cardiac Magnetic Resonance Imaging in Breast Cancer Patients: A Feasibility Study
  • Establishing a Young Adult Survivor Cardio-Oncology Clinic: A Quality Improvement Initiative
  • Trends in Global Research in Cardio-Oncology: A Bibliometric Analysis

For more information:


Related Content

An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents.  Cardio-oncology

An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

News | Cardio-oncology | February 25, 2021
February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMC
Statins Reduce Stroke, Cardiovascular Risk in Cancer Patients Following Radiation
News | Cardio-oncology | July 29, 2019
Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest, neck or head...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Heart Attack, Stroke Risks Increase Leading Up to Cancer Diagnosis
News | Cardio-oncology | December 21, 2018
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer...
Xarelto Reduces Blood Clot Events in High-Risk Cancer Patients
News | Cardio-oncology | December 07, 2018
New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE, or blood clot)...
Beta Blocker Shows Mixed Results in Protecting Against Chemo-Induced Heart Damage
News | Cardio-oncology | March 14, 2018
After six months of follow-up, women newly diagnosed with breast cancer who were given the beta blocker carvedilol to...